TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/21/20 17:00 | 8/20/20 | MNLO | Menlo Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Barbari Sharon | NJ | D | M.d | 111 | 1.48 | 0 | 75 | New | 75 | D | |||||||||||||||
9/5/13 18:01 | 9/3/13 | CYTK | Cytokinetics Inc | Health | Drug | Pharmaceutical Preparations | Barbari Sharon Surrey | CA | O | EVP,Fina | M.d | 0 | 0.00 | 8 | 17 | 205 | 25 | D | 20 | 79 | 36 | 21 | -38 | -22 | -29 | -24 | 2 | -1 | -17 | -23 | 21 | -56 | |
9/5/12 19:01 | 9/4/12 | CYTK | Cytokinetics Inc | Health | Drug | Pharmaceutical Preparations | Barbari Sharon Surrey | CA | O | EVP,Fina | M.d | 0 | 0.00 | 0 | 100 | 84 | D | -67 | -32 | -32 | -18 | 7 | 4 | 0 | -3 | 1 | 9 | 14 | -12 | 40 | 87 | ||
11/17/09 18:31 | 11/16/09 | CYTK | Cytokinetics Inc | Health | Drug | Pharmaceutical Preparations | Barbari Sharon Surrey | CA | O | EVP,Fina | M.d | 7 | 3.37 | 0 | 2 | 16 | 14 | D | -34 | 33 | 86 | 21 | -28 | -23 | 2 | 4 | 4 | 1 | -14 | -9 | -15 | -37 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |